US 11,918,813 B2
Neurostimulation titration process
Imad Libbus, St. Paul, MN (US); Bruce H. KenKnight, Maple Grove, MN (US); and Badri Amurthur, Los Gatos, CA (US)
Assigned to LivaNova USA, Inc., Houston, TX (US)
Filed by LivaNova USA, Inc., Houston, TX (US)
Filed on Nov. 29, 2021, as Appl. No. 17/537,198.
Application 17/537,198 is a continuation of application No. 16/290,783, filed on Mar. 1, 2019, granted, now 11,185,698.
Application 16/290,783 is a continuation of application No. 15/395,872, filed on Dec. 30, 2016, granted, now 10,220,212.
Application 15/395,872 is a continuation of application No. 14/457,807, filed on Aug. 12, 2014, granted, now 9,533,153.
Prior Publication US 2022/0080207 A1, Mar. 17, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/0245 (2006.01)
CPC A61N 1/36157 (2013.01) [A61B 5/0205 (2013.01); A61B 5/0245 (2013.01); A61B 5/4836 (2013.01); A61N 1/36114 (2013.01); A61N 1/36132 (2013.01); A61N 1/36139 (2013.01); A61N 1/36171 (2013.01); A61N 1/36175 (2013.01); A61B 5/02055 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A neurostimulation system, comprising:
a neurostimulator adapted to deliver a stimulation signal to a patient; and
a processor and a memory storing stimulation parameters executable by the processor to:
at an initial titration session, activate the neurostimulator to deliver the stimulation signal with an initial parameter set comprising an output current, a frequency, a pulse width, and a duty cycle;
increase the output current of the stimulation signal;
receive a first input indicating that an acceptable side effect level has been exceeded;
in response to the first input, decrease the pulse width and increase the output current of the stimulation signal;
receive a second input indicating that a target physiological response has been achieved; and
in response to the second input, maintain the stimulation signal at a current parameter set.